|Podcasts|September 14, 2011
Treating Prodromal Symptoms of Psychosis
Author(s)Irene M. Hurford, MD
Listen
0:00 / 0:00
A review of some of the latest study findings on the pharmacological treatment of prodromal psychosis.
Advertisement
What are the pros and cons of treating subtreshold high-risk psychotic symptoms? Does early intervention help or hinder patient outcomes? Can conversion to psychosis be delayed or prevented? Dr Hurford reviews some of the latest study findings on the pharmacological treatment of prodromal psychosis.
Dr Hurford is Assistant Professor in the Department of Psychiatry at the University of Pennsylvania.
Treating Prodromal Symptoms of Psychosis
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Brain Trust: Carl Salzman, MD, on Benzodiazepine Mindful Prescribing, Misuse, and Dependence
2
Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety
3
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
4
New CTx-1301 Data Affirms Pharmacokinetic Profile to Treat ADHD
5